Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo
Patient with relapsing remitting multiple sclerosis taking avonex are included in this double
 blind randomized control trial. Simvastatin is compared to placebo. end points of edss ,
 total attack, new enhancing lesion and newt2 lesion in mri is evaluated as end point.
Inclusion Criteria:

 1. edss<5

 2. >=1 attack in last year

 Exclusion Criteria:

 1. >2 attacks in study

 2. drug complication